Jazz Pharmaceuticals plc
JAZZ
$138.81
$2.361.73%
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 3.15% | 3.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 3.15% | 3.04% | |||
| Cost of Revenue | -18.54% | 1.56% | |||
| Gross Profit | 5.71% | 3.22% | |||
| SG&A Expenses | 22.70% | -3.77% | |||
| Depreciation & Amortization | 0.92% | 1.44% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 8.16% | -3.59% | |||
| Operating Income | -12.16% | 30.47% | |||
| Income Before Tax | -33.57% | 45.40% | |||
| Income Tax Expenses | -298.49% | 52.59% | |||
| Earnings from Continuing Operations | -11.13% | 27.58% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.13% | 27.58% | |||
| EBIT | -12.16% | 30.47% | |||
| EBITDA | -6.69% | 17.37% | |||
| EPS Basic | -9.85% | 30.63% | |||
| Normalized Basic EPS | -13.49% | 48.87% | |||
| EPS Diluted | -9.15% | 37.30% | |||
| Normalized Diluted EPS | -12.41% | 60.24% | |||
| Average Basic Shares Outstanding | -1.43% | -2.33% | |||
| Average Diluted Shares Outstanding | -2.65% | -9.27% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
